Manufacturers Life Insurance Company, The Cidara Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.99 - $3.25 $45,403 - $74,152	-22,816 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$2.39 - $4.0 $54,530 - $91,264	22,816 New	22,816 $86,000
Q3 2018 Nov 14, 2018	SELL	$3.7 - $5.25 $18 - $26	-5 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$4.0 - $8.15 $1,004 - $2,045	-251 Reduced 98.05%	5 $0
Q3 2017 Nov 14, 2017	BUY	$5.75 - $8.1 $1,472 - $2,073	256	256 $2,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.65B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.